Skip to main content
An official website of the United States government
Email

TARGET Molecular Characterization Platforms

Researchers working at a large-scale sequencing center.

Credit: The Broad Institute of MIT and Harvard

Below are the technologies that Therapeutically Applicable Research to Generate Effective Treatments (TARGET) used over the years. The technologies and protocols varied for each disease project type.

All nucleic acid samples used in TARGET projects were quality tested for consistency using PicoGreen quantification and short tandem repeat genotyping methods, regardless of where the nucleic acid was originally extracted.

ALL Phase 1

Protocols used for TARGET's study of Acute Lymphoblastic Leukemia Phase 1 (ALL P1)
Methodology Platform name Center

Clinical

COG Protocols (POG 9906)  
DNA Prep Qiagen QIAamp DNA Minikit Nationwide Children’s Hospital
RNA Prep Invitrogen TRIzol University of New Mexico
Gene Expression Affymetrix U133 Plus 2.0 Array University of New Mexico
Copy Number Affymetrix SNP 500K Array St. Jude Children's Research Hospital
Copy Number Affymetrix SNP Array 6.0 St. Jude Children's Research Hospital
WGS, WGS-lite Illumina HiSeq 2000/250 British Columbia Cancer Agency
WGS Complete Genomics, Inc., Complete Genomics Inc. (CGI)
mRNA-seq Illumina Hiseq 2000 British Columbia Cancer Agency
Kinome Seq Sanger British Columbia Cancer Agency
Targeted Recapture Seq Sanger British Columbia Cancer Agency

ALL Phase 2 (Expansion)

Protocols used for TARGET's study of Acute Lymphoblastic Leukemia Phase 2 (ALL P2)
Methodology Platform name Center

Clinical

COG Protocols (AALL03B1, AALL0232, P9906, AALL0331, ALL0434)  
DNA Prep Qiagen QIAamp DNA Minikit Nationwide Children’s Hospital
RNA Prep Invitrogen TRIzol University of New Mexico

Gene Expression

Affymetrix U133 Plus 2.0 Array University of New Mexico
Copy Number Affymetrix SNP 6.0 Array St. Jude Children's Research Hospital
WGS Complete Genomics, Inc. Complete Genomics Inc. (CGI)
WXS Illumina Hi-Seq 2000 Baylor College of Medicine
mRNA-seq Illumina Hi-Seq 2000 British Columbia Cancer Agency
microRNA-seq Illumina Hiseq 2000 British Columbia Cancer Agency
Methylation HELP Assay with Roche NimbleGen Weill Cornell Medical College

ALL Phase 3 (ALAL)

Protocols used for TARGET's study of Acute Leukemia of Ambiguous Lineage (ALAL)
Methodology Platform name Center
Clinical    
Copy Number Illumina Infinium Omni2.5 Exome8 Kit St. Jude Children's Research Hospital
Methylation Illumina Infinium MethylationEPIC St. Jude Children's Research Hospital
WGS Illumina HiSeq2500 St. Jude Children's Research Hospital
WXS Illumina HiSeq2500 St. Jude Children's Research Hospital
mRNA-seq Illumina HiSeq2000 St. Jude Children's Research Hospital

AML

Protocols used for TARGET's study of Acute Myeloid Leukemia (AML)
Methodology Platform name Center

Clinical

COG Protocols (CCG-2961, AAML03P1, AAML0531)  
DNA and RNA Prep Qiagen AllPrep (DNA/RNA), mirVana (total and small RNAs) Fred Hutchinson Cancer Research Center
Gene Expression Affymetrix Gene ST Array Hudson Alpha, Fred Hutchinson Cancer Research Center
Copy Number Affymetrix SNP 6.0 Array Fred Hutchinson Cancer Research Center
Methylation Illumina Infinium 27K Johns Hopkins University
Methylation Illumina Infinium 450K Phoenix Children's Hospital
WGS Complete Genomics, Inc. Complete Genomics Inc. (CGI)
WXS Illumina Hi-Seq 2000 Baylor College of Medicine
mRNA-seq Illumina Hi-Seq 2000 British Columbia Cancer Agency
Targeted Capture Seq Illumina Hi-Seq 2500 British Columbia Cancer Agency and Fred Hutchinson Cancer Research Center

AML Induction Failure

Protocols used for TARGET's study of Acute Myeloid Leukemia - Induction Failure (AML-IF)
Methodology Platform name Center

Clinical Annotation

COG Protocols (AAML0531, AAML03P1)  
DNA and RNA Prep Qiagen AllPrep (DNA/RNA) and mirVana (total and small RNAs) Fred Hutchinson Cancer Research Center
mRNA-seq Illumina Hi-Seq 2000 British Columbia Cancer Agency
microRNA-seq Illumina Hi-Seq 2000 British Columbia Cancer Agency

Kidney - Wilms Tumor

Protocols used for TARGET's study of Wilms Tumor (WT)
Methodology Platform name Center

Clinical Annotation

NWTS – 5 Protocol  
DNA and RNA Prep Qiagen AllPrep kit (DNA/RNA) and mirVana (total and small RNAs) Nationwide Children’s Hospital
Gene Expression Affymetrix U133 Plus 2.0 Array Lurie Children's Hospital Research Center
Copy Number Affymetrix SNP 6.0 Array St. Jude Children's Research Hospital, Lurie Children's Hospital Research Center
Methylation Illumina Infinium 450K Lurie Children's Hospital Research Center
WGS Complete Genomics, Inc. Complete Genomics, Inc.
WXS Illumina Hi-Seq 2000 Baylor College of Medicine
mRNA-seq Illumina Hi-Seq 2000 British Columbia Cancer Agency
microRNA-seq Illumina Hi-Seq 2000 British Columbia Cancer Agency
Targeted Capture Seq Illumina Hi-Seq 2500 British Columbia Cancer Agency and Fred Hutchinson Cancer Research Center

Kidney - Clear Cell Sarcoma

Protocols used for TARGET's study of Clear Cell Sarcoma of the Kidney (CCSK)
Methodology Platform name Center

Clinical

NWTS-5 Protocol  
DNA and RNA Prep Qiagen AllPrep kit (DNA/RNA) and mirVana (total and small RNAs) Nationwide Children’s Hospital 
Gene Expression Affymetrix U133 Plus 2.0 Array Lurie Children's Hospital Research Center
Copy Number Affymetrix SNP 6.0 Array St. Jude Children's Research Hospital, Lurie Children's Hospital Research Center
Methylation Illumina Infinium 450K Lurie Children's Hospital Research Center
WGS Complete Genomics Inc. (CGI) Complete Genomics Inc. (CGI)
mRNA-seq Illumina Hi-Seq 2000 NCI Center for Cancer Research

Kidney - Rhabdoid Tumor

Protocols used for TARGET's study of Rhabdoid Tumor (RT)
Methodology Platform name Center

Clinical Annotation

AREN03B2 or NWTS-5 Protocols  
DNA and RNA Prep Qiagen AllPrep kit (DNA/RNA) and mirVana (total and small RNAs) Nationwide Children’s Hospital
WGS Illumina Hi-Seq 2000/2500 British Columbia Cancer Agency
mRNA-seq Illumina Hiseq 2000 British Columbia Cancer Agency
microRNA-seq Illumina Hiseq 2000 British Columbia Cancer Agency
Bisulfite-seq Illumina Hi-Seq 2500  
ChIP-seq Illumina Hi-Seq 2000  

Neuroblastoma

Protocols used for TARGET's study of Neuroblastoma (NBL)
Methodology Platform name Center

Clinical Annotation

COG NBL Protocols  
DNA and RNA Prep Qiagen AllPrep kit (DNA/RNA) and mirVana (total and small RNAs) Nationwide Children’s Hospital (after 2013)
DNA Prep Qiagen Genomic-Tips Nationwide Children’s Hospital (prior 2013)
RNA Prep Invitrogen TRIzol and Qiagen RNAeasy Nationwide Children’s Hospital (prior 2013)
Gene Expression Affymetrix Human Exon ST Array Children's Hospital Los Angeles, Children's Hospital of Philadelphia, or Children's Oncology Group Biopathology Center at Colombus, Ohio.
Copy Number Illumina HumanHap 550K Beadchip Children's Hospital of Philadelphia
Methylation Illumina Infinium 450K USC Epigenome Center
WGS Illumina Genome Analyzer IIx or Hi-Seq 2000 British Columbia Cancer Agency
WGS Complete Genomics Inc. Complete Genomics Inc., 
WXS Illumina Genome Analyzer II or Hi-Seq 2000 Broad Institute
WXS (MDLS models) Illumina Hi-Seq 2000 Baylor College of Medicine
mRNA-seq Illumina Hi-Seq 2000 British Columbia Cancer Agency
mRNA-seq Illumina Hi-Seq 2000 NCI Center for Cancer Research
Targeted Capture Seq Illumina Hi-Seq 2500 British Columbia Cancer Agency and Fred Hutchinson Cancer Research Center

Osteosarcoma

Protocols used for TARGET's study of Osteosarcoma (OS)
Methodology Platform name Center

Clinical Annotation

COG & SickKids Protocols  
DNA and RNA Prep Qiagen AllPrep kit (DNA/RNA) and mirVana (total and small RNAs) Nationwide Children’s Hospital
Gene Expression Affymetrix Human Exon ST Array Children’s Hospital of Los Angeles, Texas Children’s Hospital
Copy Number Affymetrix SNP 6.0 Array Children’s Hospital of Los Angeles
Methylation Illumina Infinium 450K Phoenix Children’s Hospital, Baylor College of Medicine
microRNA Profiling MegaPlex TaqMan Array Baylor College of Medicine
WGS Complete Genomics Inc. (CGI) Complete Genomics Inc. (CGI)

Model Systems

Protocols used for TARGET's Model Systems (MDLS) and Pediatric Preclinical Testing Program (PPTP)
Methodology Platform name Center

DNA Prep

Qiagen QIAamp DNA Minikit (ALL MDLS) Nationwide Children’s Hospital
RNA Prep Invitrogen TRIzol (ALL MDLS) University of New Mexico
Gene Expression Affymetrix U133 Plus 2.0 Array (ALL MDLSPPTP) University of New Mexico (ALL MDLS)
Gene Expression SurePrint G3 Human Gene Expression Array (PPTP)  
Copy Number Affymetrix SNP 6.0 Array (PPTP) Nationwide Children's Hospital
Copy Number Illumina Omni5 BeadChip (PPTP) Nationwide Children's Hospital
WXS Illumina Hi-Seq 2000 (NBL MDLS, PPTP) Baylor College of Medicine

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “TARGET Molecular Characterization Platforms was originally published by the National Cancer Institute.”

Email